Tirzepatide week 1: what the science says vs. the hype

What did @_sacha_fierce actually say?

The creator says she lost 9 pounds in her first week on tirzepatide, took two shots in seven days, and now barely eats, surviving mostly on water. She also promotes a $25 discount from her doctor for anyone who mentions her name, and hopes to lose another 9 pounds next week.

To be specific about the claims: she says she "literally don't have an appetite," isn't getting enough protein, and is eating only once a day. She describes fatigue as a side effect but frames it as minor. The video functions as both a personal update and a direct promotional post for a telehealth provider who ships compounded tirzepatide to her door. Those two things, personal testimony and paid-adjacent promotion, deserve to be evaluated separately.

Does the science back this up?

A 9-pound drop in week one is plausible but almost certainly not 9 pounds of fat. The evidence suggests most of it is water and glycogen. That distinction matters a lot when someone is publicly setting expectations for 270,000 viewers.

In the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine), participants on tirzepatide lost an average of 20.9% of body weight over 72 weeks, not in a week. Early weight loss on GLP-1 and dual GIP/GLP-1 agonists is well-documented to include significant fluid loss as appetite suppression reduces carbohydrate intake and glycogen stores drop. A 2021 review by Hall and Guo in Cell Metabolism confirmed that rapid early weight loss on low-calorie intake consistently reflects fluid, not fat tissue. Projecting another 9 pounds next week is not how tirzepatide works, and saying so publicly without that context is misleading to a large audience.

What did they get wrong (or right)?

She got the appetite suppression part right. Tirzepatide's dual mechanism, acting on both GIP and GLP-1 receptors, produces meaningful reductions in hunger. That is well-supported. The fatigue she mentions is also a documented early side effect.

What she got wrong, or at least dangerously incomplete: she openly admits she is "not getting enough protein" and eating once a day, and frames this as fine. It is not fine. During rapid weight loss, inadequate protein intake accelerates lean muscle loss. A 2022 study by Cava et al. in Nutrients found that protein intake below 1.2 grams per kilogram of body weight during caloric restriction significantly increases lean mass loss. Tirzepatide does not protect muscle by default. She also conflates water weight loss with fat loss in a way that will set unrealistic expectations for her followers. The week-two projection of "another nine" is not grounded in how this drug behaves after the initial drop.

What should you actually know?

Early dramatic weight loss on tirzepatide is real, but it is not representative of ongoing results, and it does not mean the drug is working harder for you than it will next month. Understanding why that number is high in week one changes how you manage expectations and how you eat.

The protein issue she raises herself is the most actionable concern here. GLP-1 and dual-agonist medications suppress appetite broadly, which means people often undereat protein without realizing it. Research published by Wilding et al. in 2021 in NEJM on semaglutide (a related GLP-1 agonist) showed that lean mass preservation during weight loss required deliberate protein and resistance training interventions. Tirzepatide is not meaningfully different in this respect. Drinking protein shakes, as she plans to do, is genuinely the right instinct. Following through on that matters more than the scale number in week one.

One more thing worth naming: this video is promotional. A doctor's team is in the comments, there is a discount code tied to the creator's name, and the medication ships directly. That is a sponsored health recommendation, and viewers should weigh it accordingly.